US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist

16.810
-2.210-11.62%

Close Jun 18 16:00 ET

968.83MMarket Cap-5370P/E (TTM)

Cullinan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

25.00%-38.25M

-6.01%-134.28M

27.43%-18.13M

37.19%-34.14M

-21.97%-31.01M

-132.78%-51M

-191.63%-126.66M

-64.68%-24.98M

-415.15%-54.35M

-56.95%-25.42M

Net income from continuing operations

35.78%-37.34M

-242.04%-155.1M

5.63%-25.56M

-57.42%-39.18M

-118.51%-32.21M

-350.99%-58.14M

261.81%109.2M

20.81%-27.09M

-36.32%-24.89M

1,158.85%174.07M

Operating gains losses

----

---276.75M

---91K

--14K

----

Depreciation and amortization

5.56%76K

233.33%310K

30.51%77K

788.89%80K

575.00%81K

453.85%72K

75.47%93K

391.67%59K

-30.77%9K

-7.69%12K

Other non cash items

----

-64.97%131K

-45.96%127K

--0

--4K

458.21%374K

--235K

--0

----

Change In working capital

-600.34%-5.9M

-103.03%-339K

166.05%3.31M

99.48%-181K

-109.67%-4.65M

-61.03%1.18M

415.62%11.18M

-187.10%-5.01M

-1,678.39%-34.91M

1,097.37%48.07M

-Change in prepaid assets

154.44%411K

-426.02%-5.94M

-428.73%-3.29M

-801.84%-3.81M

2,028.89%1.92M

33.77%-755K

65.43%-1.13M

-133.95%-623K

471.58%543K

110.63%90K

-Change in payables and accrued expense

-426.36%-6.32M

-54.45%5.61M

250.50%6.6M

110.24%3.63M

-113.68%-6.56M

-53.57%1.94M

4,624.26%12.31M

-212.00%-4.39M

-1,774.87%-35.46M

1,307.73%47.98M

Cash from discontinued investing activities

Operating cash flow

25.00%-38.25M

-6.01%-134.28M

27.43%-18.13M

37.19%-34.14M

-21.97%-31.01M

-132.78%-51M

-191.63%-126.66M

-64.68%-24.98M

-415.15%-54.35M

-56.95%-25.42M

Investing cash flow

Cash flow from continuing investing activities

-14.67%12.96M

-85.62%35.81M

279.90%51.47M

25.91%-42.96M

-95.97%12.11M

-56.26%15.18M

174.59%248.98M

-80.37%-28.61M

-126.54%-57.98M

294.61%300.85M

Net PPE purchase and sale

--0

80.04%-208K

--0

---49K

---159K

---1.04M

---791K

---251K

--0

Net business purchase and sale

----

--0

----

--275M

--0

--5M

----

Net investment purchase and sale

-15.56%12.96M

244.15%36.01M

285.02%51.47M

31.52%-42.96M

-60.59%12.16M

-55.80%15.34M

92.52%-24.98M

-75.38%-27.82M

-145.09%-62.73M

119.96%30.85M

Cash from discontinued investing activities

Investing cash flow

-14.67%12.96M

-85.62%35.81M

279.90%51.47M

25.91%-42.96M

-95.97%12.11M

-56.26%15.18M

174.59%248.98M

-80.37%-28.61M

-126.54%-57.98M

294.61%300.85M

Financing cash flow

Cash flow from continuing financing activities

-39.35%1.09M

257.14%40.75M

100.75%248K

-92.14%112K

1,817.64%38.6M

-49.48%1.79M

-109.65%-25.93M

-1,318.06%-32.91M

146.11%1.43M

118.09%2.01M

Net issuance payments of debt

--0

942.86%1.83M

--0

128.13%1.83M

--175K

--0

---800K

Net common stock issuance

----

--38.39M

--0

----

--0

----

Proceeds from stock option exercised by employees

3,113.89%1.09M

-91.06%538K

27.84%248K

-92.14%112K

-92.39%214K

-102.27%-36K

83.48%6.02M

-92.82%194K

146.11%1.43M

--2.81M

Net other financing activities

----

-1,720.28%-32.13M

---33.28M

--0

Cash from discontinued financing activities

Financing cash flow

-39.35%1.09M

257.14%40.75M

100.75%248K

-92.14%112K

1,817.64%38.6M

-49.48%1.79M

-109.65%-25.93M

-1,318.06%-32.91M

146.11%1.43M

118.09%2.01M

Net cash flow

Beginning cash position

-36.96%98.43M

161.24%156.15M

-73.28%64.85M

-59.88%141.83M

60.45%122.13M

161.24%156.15M

-64.46%59.77M

175.42%242.66M

185.89%353.56M

-74.07%76.12M

Current changes in cash

28.86%-24.21M

-159.89%-57.72M

138.83%33.59M

30.58%-76.99M

-92.90%19.71M

-308.17%-34.02M

188.89%96.38M

-205.34%-86.51M

-211.84%-110.91M

263.33%277.45M

End cash Position

-39.22%74.23M

-36.96%98.43M

-73.28%64.85M

-59.88%141.83M

60.45%122.13M

161.24%156.15M

175.42%242.66M

185.89%353.56M

Free cash flow

25.23%-38.25M

-5.23%-134.48M

29.90%-18.13M

37.48%-34.14M

-22.17%-31.06M

-133.50%-51.16M

-194.24%-127.8M

-70.49%-25.87M

-417.52%-54.6M

-56.95%-25.42M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	25.00%-38.25M	-6.01%-134.28M	27.43%-18.13M	37.19%-34.14M	-21.97%-31.01M	-132.78%-51M	-191.63%-126.66M	-64.68%-24.98M	-415.15%-54.35M	-56.95%-25.42M
Net income from continuing operations	35.78%-37.34M	-242.04%-155.1M	5.63%-25.56M	-57.42%-39.18M	-118.51%-32.21M	-350.99%-58.14M	261.81%109.2M	20.81%-27.09M	-36.32%-24.89M	1,158.85%174.07M
Operating gains losses	----	----	----	----	----	----	---276.75M	---91K	--14K	----
Depreciation and amortization	5.56%76K	233.33%310K	30.51%77K	788.89%80K	575.00%81K	453.85%72K	75.47%93K	391.67%59K	-30.77%9K	-7.69%12K
Other non cash items	----	-64.97%131K	-45.96%127K	--0	--0	--4K	458.21%374K	--235K	--0	----
Change In working capital	-600.34%-5.9M	-103.03%-339K	166.05%3.31M	99.48%-181K	-109.67%-4.65M	-61.03%1.18M	415.62%11.18M	-187.10%-5.01M	-1,678.39%-34.91M	1,097.37%48.07M
-Change in prepaid assets	154.44%411K	-426.02%-5.94M	-428.73%-3.29M	-801.84%-3.81M	2,028.89%1.92M	33.77%-755K	65.43%-1.13M	-133.95%-623K	471.58%543K	110.63%90K
-Change in payables and accrued expense	-426.36%-6.32M	-54.45%5.61M	250.50%6.6M	110.24%3.63M	-113.68%-6.56M	-53.57%1.94M	4,624.26%12.31M	-212.00%-4.39M	-1,774.87%-35.46M	1,307.73%47.98M
Cash from discontinued investing activities
Operating cash flow	25.00%-38.25M	-6.01%-134.28M	27.43%-18.13M	37.19%-34.14M	-21.97%-31.01M	-132.78%-51M	-191.63%-126.66M	-64.68%-24.98M	-415.15%-54.35M	-56.95%-25.42M
Investing cash flow
Cash flow from continuing investing activities	-14.67%12.96M	-85.62%35.81M	279.90%51.47M	25.91%-42.96M	-95.97%12.11M	-56.26%15.18M	174.59%248.98M	-80.37%-28.61M	-126.54%-57.98M	294.61%300.85M
Net PPE purchase and sale	--0	80.04%-208K	--0	--0	---49K	---159K	---1.04M	---791K	---251K	--0
Net business purchase and sale	----	--0	--0	--0	----	----	--275M	--0	--5M	----
Net investment purchase and sale	-15.56%12.96M	244.15%36.01M	285.02%51.47M	31.52%-42.96M	-60.59%12.16M	-55.80%15.34M	92.52%-24.98M	-75.38%-27.82M	-145.09%-62.73M	119.96%30.85M
Cash from discontinued investing activities
Investing cash flow	-14.67%12.96M	-85.62%35.81M	279.90%51.47M	25.91%-42.96M	-95.97%12.11M	-56.26%15.18M	174.59%248.98M	-80.37%-28.61M	-126.54%-57.98M	294.61%300.85M
Financing cash flow
Cash flow from continuing financing activities	-39.35%1.09M	257.14%40.75M	100.75%248K	-92.14%112K	1,817.64%38.6M	-49.48%1.79M	-109.65%-25.93M	-1,318.06%-32.91M	146.11%1.43M	118.09%2.01M
Net issuance payments of debt	--0	942.86%1.83M	--0	--0	--0	128.13%1.83M	--175K	--175K	--0	---800K
Net common stock issuance	----	--38.39M	--0	--0	----	----	--0	--0	--0	----
Proceeds from stock option exercised by employees	3,113.89%1.09M	-91.06%538K	27.84%248K	-92.14%112K	-92.39%214K	-102.27%-36K	83.48%6.02M	-92.82%194K	146.11%1.43M	--2.81M
Net other financing activities	----	----	----	----	----	----	-1,720.28%-32.13M	---33.28M	--0	--0
Cash from discontinued financing activities
Financing cash flow	-39.35%1.09M	257.14%40.75M	100.75%248K	-92.14%112K	1,817.64%38.6M	-49.48%1.79M	-109.65%-25.93M	-1,318.06%-32.91M	146.11%1.43M	118.09%2.01M
Net cash flow
Beginning cash position	-36.96%98.43M	161.24%156.15M	-73.28%64.85M	-59.88%141.83M	60.45%122.13M	161.24%156.15M	-64.46%59.77M	175.42%242.66M	185.89%353.56M	-74.07%76.12M
Current changes in cash	28.86%-24.21M	-159.89%-57.72M	138.83%33.59M	30.58%-76.99M	-92.90%19.71M	-308.17%-34.02M	188.89%96.38M	-205.34%-86.51M	-211.84%-110.91M	263.33%277.45M
End cash Position	-39.22%74.23M	-36.96%98.43M	-36.96%98.43M	-73.28%64.85M	-59.88%141.83M	60.45%122.13M	161.24%156.15M	161.24%156.15M	175.42%242.66M	185.89%353.56M
Free cash flow	25.23%-38.25M	-5.23%-134.48M	29.90%-18.13M	37.48%-34.14M	-22.17%-31.06M	-133.50%-51.16M	-194.24%-127.8M	-70.49%-25.87M	-417.52%-54.6M	-56.95%-25.42M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall